Frontlight ResearchEarly access
CompletedPhase 1/2
Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women
Key facts
- Who runs it
- University of Vermont
- Where
- Burlington and Lexington, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- Phase
- Phase 1/2
- People taking part
- 30 people enrolled
- Started
- 21 Aug 2019
- Ended
- 19 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Very low nicotine content cigarettes
- Record updated
- 18 May 2026
Who can take part
- Age
- 18 years to 44 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Female
- Ages 18-44 years
- Gestational age ≤ 25 weeks
Who cannot take part
- Under 18 years old
- Over 44 years old
- Gestational age > 25 weeks
- Male
Where in United States
- University of VermontBurlington, United States
- University of KentuckyLexington, United States
About the trial
What the trial wants to find out
Study 2 will evaluate the effects of extended exposure to cigarettes with varying levels of nicotine in pregnant smokers who have less than an Associate's degree. This study will be limited to two conditions: usual brand vs. 0.4 mg nicotine/g tobacco. After a baseline period in which daily smoking rate and other baseline assessments are completed, participants will be randomly (by chance) assigned to either their usual brand or the very low nicotine content condition and followed for 12 weeks.
The 2 groups in the trial
- Very low nicotine content cigarettesTreatment being tested
- Usual BrandNo study treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 18 May 2026